STE71

Caenorhabditis elegans

STE70

Caenorhabditis elegans

STE69

Caenorhabditis elegans

nlp-26

Caenorhabditis elegans

Predicted to be involved in neuropeptide signaling pathway. Expressed in several structures, including P2.p; P3.pa; P3.pp; P4.pa; and P4.pp.

STE72

Caenorhabditis elegans

STE68

Caenorhabditis elegans

chw-1

Caenorhabditis elegans

Predicted to enable GTP binding activity; GTPase activity; and protein kinase binding activity. Involved in establishment or maintenance of cell polarity and vulval development. Predicted to be located in plasma membrane. Expressed in several structures, including P3.pa; P3.pp; P4.pa; P4.pp; and P8.pa. Is an ortholog of human RHOU (ras homolog family member U).

STE73

Caenorhabditis elegans

HS616

Caenorhabditis elegans

algn-11

Caenorhabditis elegans

Predicted to enable GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity. Predicted to be involved in dolichol-linked oligosaccharide biosynthetic process. Predicted to be located in endoplasmic reticulum membrane. Human ortholog(s) of this gene implicated in congenital disorder of glycosylation Ip. Is an ortholog of human ALG11 (ALG11 alpha-1,2-mannosyltransferase).